• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Emcure Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 16966.0
  • ISIN : INE168P01015
1,978.90 16 (0.82%)
  • As on 12 Sep 2026 (EOD)

  • Today’s Low

    1,948.20

  • Today’s High

    1,999.00

  • Open

    1,965.00

  • Perv Close

    1,962.80

  • 52W Low

    1,260.00

  • 52W High

    2,048.00

Key Indicators

  • P/E(TTM)

    45.30

  • Mar.Cap (₹Cr.)

    37,539.58

  • Div & Yield %

    0.18

  • Book Value(₹)

    195.61

  • Debt-Equity Ratio

    0.82

  • AGM Date

    11-Sep-2026

  • EPS

    43.64

  • P/E Ratio

    45.30

Financials Ratios

  • Debt-Equity Ratio

    0.86

  • Mar.Cap (₹Cr.)

    37,539.58

  • RONW (%)

    19.35

  • ROCE (%)

    18.23

Score Board

  • Equity (₹ in Cr.)

    189.70

  • BV (₹)

    195.60

  • Sales( ₹ in Cr.)

    5,243.19

  • NP (in Cr.)

    751.96

  • NP Var(%)

    180.0

  • Div%

    36.0

  • CPS (₹)

    52.60

  • EPS (₹)

    39.60

  • Traded Value (₹ in Lakhs)

    37,498.80

  • 52 Week High

    2,048.00

  • 52 Week Low

    1,260.00

  • Price BSE

    1977.0

  • Price NSE

    1,979.00

  • Market Capital( in Cr.)

    37,498.80

  • P/C Ratio

    37.60

  • P/E Ratio

    49.90

  • Price Vs.BV

    39.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 5,243.19 4,381.92 3,497.66 3,107.09 3,387.24 3,153.66
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 5,243.19 4,381.92 3,497.66 3,107.09 3,387.24 3,153.66
Other Income 311.66 142.48 138.26 125.35 132.68 111.91
Stock Adjustments 130.94 126.27 101.70 -14.45 36.10 107.96
Total Income 5,685.79 4,650.67 3,737.62 3,217.99 3,556.02 3,373.53
EXPENDITURE :            
Raw Materials 2,369.76 2,133.68 1,464.67 1,199.25 1,354.99 1,354.36
Power and Fuel Cost 103.67 99.86 88.73 80.41 72.46 73.92
Employee Cost 821.12 782.31 706.41 649.18 603.95 550.96
Other Manufacturing Expenses 341.28 275.56 209.89 192.67 219.39 142.20
Selling and Administration Expenses 538.48 473.67 532.82 443.20 263.11 341.49
Miscellaneous Expenses 202.29 119.95 164.27 95.59 114.78 73.58
Employee Benefit Expenses 821.12 782.31 706.41 649.18 603.95 550.96
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4,376.59 3,885.03 3,166.78 2,660.30 2,628.67 2,536.51
Operating Profit 1,309.19 765.64 570.83 557.69 927.36 837.02
Interest 118.27 112.96 166.09 166.83 145.14 123.34
Gross Profit 1,190.92 652.68 404.74 390.86 782.22 713.68
Depreciation 246.73 224.97 204.83 178.52 165.79 156.24
Profit Before Tax 944.19 427.71 199.91 212.34 616.43 557.44
Current Tax 233.74 112.71 38.58 53.10 168.72 141.13
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -22.51 -2.13 0.50 -0.83 0.89 -4.15
Reported Net Profit 732.96 317.13 160.83 160.06 446.81 420.48
Extraordinary Items -19.00 48.95 -1.64 -4.80 0.10 -13.20
Adjusted Net Profit 751.96 268.18 162.47 164.86 446.71 433.68
Adjustment below Net Profit 0.65 -1.21 -5.34 4.06 -0.79 0.11
P & L Balance brought forward 2,011.00 1,695.08 1,593.84 1,465.89 1,877.11 1,474.61
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 56.85 0.00 54.26 36.17 857.24 18.09
P & L Balance carried down 2,687.75 2,011.00 1,695.08 1,593.84 1,465.89 1,877.11
Dividend 0.00 0.00 36.17 0.00 36.17 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 36.00 30.00 20.00 20.00 30.00 10.00
Dividend Per Share(Rs) 3.60 3.00 2.00 2.00 3.00 1.00
Earnings Per Share-Unit Curr 38.66 16.74 8.88 8.85 24.71 23.25
Earnings Per Share(Adj)-Unit Curr 38.66 16.74 - - - -
Book Value 195.72 159.61 106.82 101.84 94.69 127.27
Book Value(Adj)-Unit Curr 195.72 159.61 - - - -

Shareholding Pattern

  • Promoter Group

    77.83%

  • Public Share Holding

    22.17%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 433,932 433,932.00 433,932 433,932
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 433,932 0.23 433,932 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 118,166,268 62.30 118,166,268 16
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 29,028,000 15.30 29,028,000 2
Others 0 0.00 0 0
Sub Total 147,194,268 77.60 147,194,268 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,248,970 4.88 9,248,970 116
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,529,886 1.33 2,529,886 4
Mutual Funds / UTI 13,021,870 6.87 13,021,870 23
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 502,079 0.26 502,079 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 25,302,805 13.34 25,302,805 159
2] Non Institution
Bodies Corporate 2,222,865 1.17 2,222,865 382
Clearing Members 18,092 0.01 18,092 17
Directors of their Relatives 295,716 0.16 295,716 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,417,344 0.75 1,417,344 1,662
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 235,139 0.12 235,139 2,911
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,541,069 3.45 6,520,469 46
Individuals holding nominal share capital up to Rs. 1 lakh 5,699,009 3.00 5,699,005 119,731
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,103 0.00 2,103 4
Others 30,750 0.02 30,750 1
Sub Total 16,749,142 8.83 16,728,538 124,812
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 189,680,147 100.00 189,659,543 124,991

Company Background

Emcure Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Emcure Pharmaceuticals Ltd
  • BSE Code : 16966.0
  • ISIN : INE168P01015

  • Incorporation Year

    1981

  • Registered Office

    Plot # P-1 & P-2 IT BT Park
    Phase II MIDC Hinjawadi, Pune,
    Maharashtra-411057

  • Telephone

    +91 20 3507 0033/+91 20 3507 0000

  • FAX

  • Chairman

    SATISH RAMANLAL MEHTA

  • Managing Director

  • Company Secretary

    Amruta Jana Yangalwar

  • Auditor

    BSR & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Emcure Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Emcure Pharma 1,976.75 5,554.84 5,243.19 46.28 22.83
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77